3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Does finasteride treatment for benign prostatic hyperplasia influence sperm DNA integrity in dogs?

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Benign prostatic hyperplasia (BPH) is one of the most common reproductive disorders in both male dogs and men. Finasteride, a synthetic inhibitor of the enzyme 5α-reductase, is widely used as medical treatment. Although sperm can be affected by both BPH and finasteride treatment, the direct influence on DNA integrity remains unclear. Thus, the aim of this study was to verify the direct effect of BPH and/or finasteride treatment on DNA integrity of dog spermatozoa. A 2 × 2 factorial experiment was designed with 20 male dogs assigned to 4 experimental groups: BPH Group ( n = 5), BPH-Finasteride Group ( n = 5), Non-BPH Finasteride-Treated Group (n = 5) and Non-BPH Untreated Group (n = 5). Sperm evaluation was performed monthly for 60 days after the start of finasteride therapy or BPH diagnosis (D0, D30 and D60). Sperm DNA integrity was analyzed through fragmentation susceptibility (toluidine blue staining and Sperm Chromatic Structure Assay - SCSA), direct evaluation of DNA fragmentation (Sperm Chromatin Dispersion Assay - SCDA) and sperm protamination (chromomycin A3).

          Results

          Sperm DNA integrity was not affected by finasteride treatment. However, BPH dogs had higher susceptibility to sperm DNA acid denaturation (SCSA) compared to dogs not presenting BPH, as well as lower percentage of sperm with DNA integrity (toluidine blue staining).

          Conclusion

          In conclusion, benign prostatic hyperplasia causes post-testicular sperm DNA damage, albeit finasteride treatment itself does not directly influence sperm DNA integrity.

          Résumé

          Contexte

          L’hyperplasie bénigne de la prostate (HBP) est l’un des troubles de la reproduction les plus courants chez le chien et chez l’homme. Le finastéride, un inhibiteur synthétique de l’enzyme 5α-réductase, est largement utilisé comme traitement médical. Bien que le sperme puisse être affecté à la fois par l’HBP et par le traitement avec le finastéride, l’influence directe sur l’intégrité de l’ADN reste peu claire.

          Le but de cette étude était ainsi de vérifier l’effet direct de l’HBP et/ou du traitement par finastéride sur l’intégrité de l’ADN des spermatozoïdes de chien. Dans la présente étude, 20 chiens mâles ont été randomisés selon un plan factoriel en 2x2 à l’un des 4 groupes expérimentaux suivants : Groupe HBP (n=5), Groupe HBP-Finastéride (n=5), Groupe non-HBP traité par Finastéride (n=5), et Groupe non-HBP non traité (n=5). L’analyse Le sperme a été réalisée mensuellement pendant 60 jours (J0, J30 et J60) soit après le début du traitement par finastéride ou à partir du diagnostic de HBP. L’intégrité de l’ADN des spermatozoïdes a été analysée par l’évaluation de la susceptibilité à la fragmentation (coloration au bleu de toluidine ; détermination de la structure de la chromatine des spermatozoïdes - SCSA), par l’évaluation directe de la fragmentation de l’ADN des spermatozoïdes (détermination de la dispersion de la chromatine des spermatozoïdes - SCDA) et par l’évaluation de la protamination des spermatozoïdes (chromomycine A3).

          Résultats

          L’intégrité de l’ADN des spermatozoïdes n’a pas été affectée par le traitement par finastéride. Cependant, les chiens avec HBP ont une susceptibilité plus élevée à la dénaturation acide de l’ADN des spermatozoïdes (SCSA) par comparaison aux chiens ne présentant pas d’HBP, ainsi qu’un pourcentage plus bas de spermatozoïdes avec intégrité de l’ADN (coloration au bleu de toluidine).

          Conclusions

          L’hyperplasie bénigne de la prostate induit des altérations de l’ADN des spermatozoïdes, alors que le traitement par finastéride n’influence pas directement par lui-même l’intégrité de l’ADN des spermatozoïdes.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Presence of endogenous nicks in DNA of ejaculated human spermatozoa and its relationship to chromomycin A3 accessibility.

          During spermiogenesis, mammalian chromatin undergoes replacement of nuclear histones by protamines, resulting in a DNA that is highly condensed in the mature sperm. We have previously demonstrated that a percentage of human spermatozoa exhibit 1) positivity to the guanine-cylosine-specific chromomycin A3 (CMA3) fluorochrome and 2) the presence of endogenous nicks in their DNA. In situ protamination of mature human sperm limits the percentage of sperm positive to CMA3 and exhibiting endogenous nicks. In this study, we report further investigations that aim to clarify the relationship existing between levels of CMA3 stainability and the presence of endogenous nicks in the DNA of mature human spermatozoa. Human spermatozoa from 25 different samples showed values of sensitivity to the CMA3 fluorochrome ranging from 13% to 75%. The same samples showed a percentage of sensitivity to endogenous nick translation ranging from 1% to 38%. A strong correlation (r = 0.86) was evident between these two parameters. Prior staining of sperm with the CMA3 fluorochrome drastically reduced sensitivity to nick translation. In contrast, previously nick-translated sperm stained with CMA3 showed very little difference from samples that had not been pretreated. The presence of nicked sperm in the ejaculate may indicate anomalies during spermiogenesis and be an indicator of male infertility.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Levels of FSH, LH and testosterone, and sperm DNA fragmentation.

            Having an offspring is the most important human biological goal, which is necessary for survival of the human species. Lack of offspring is a phenomenon concerning approximately 15% of married couples in Poland. In a half of the cases, a causative agent is the male factor infertility problem. There is evidence that certain male fertility problems are related with disorders of the process of spermatogenesis. The course of normal spermatogenesis depends on proper pituitary secretion of folliculostimulin (FSH), luteinizing hormone (LH), as well as testicular secretion of testosterone. It is considered that in approximately 20% of patients with idiopathic infertility an elevated level of sperm DNA fragmentation may be the cause of failure in reproduction. The objective of the present study was determination of the relationship between FSH, LH and testosterone levels, and the occurrence of sperm DNA fragmentation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              In-situ competition between protamine and fluorochromes for sperm DNA.

              In this study we investigated the relationship between the presence of bound protamine on mouse and human sperm DNA and the level of chromomycin A3 (CMA3) and 4'6-diamidino-2-phenylindole (DAPI) fluorescence. This was accomplished by performing a competition assay between salmon protamine and fluorochromes on decondensed spermatozoa that had their nuclear proteins extracted and were fixed on slides. Various concentrations (0, 0.005, 0.0225, 0.05, 0.225, 0.5 and 5 mg/ml) of salmon protamine were added to either the CMA3 or DAPI staining solutions. Fluorescence emission measurements of stained sperm nuclei were then performed using a microfluorometer. When the treated decondensed sperm heads were stained with either CMA3 or DAPI all spermatozoa were found to fluoresce intensely. The addition of protamines to the spermatozoa led to an elimination of CMA3 fluorescence, while the intensity of DAPI staining was decreased to approximately 50% at the highest concentrations of protamine. The addition of increasing amounts of salmon protamine also induced the sperm nuclei to regain their initial condensed appearance. This study shows that protamine retains a strong affinity for sperm DNA in situ and that CMA3 fluorescence is a strong indicator of the protamination state of spermatozoa.
                Bookmark

                Author and article information

                Contributors
                cacavann@usp.br
                Journal
                Basic Clin Androl
                Basic Clin Androl
                Basic and Clinical Andrology
                BioMed Central (London )
                2051-4190
                16 July 2020
                16 July 2020
                2020
                : 30
                : 9
                Affiliations
                [1 ]GRID grid.11899.38, ISNI 0000 0004 1937 0722, Department of Animal Reproduction, School of Veterinary Medicine and Animal Science, , University of São Paulo, ; Av. Prof. Orlando Marques de Paiva, 87, São Paulo, 05508-270 Brazil
                [2 ]GRID grid.5342.0, ISNI 0000 0001 2069 7798, Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, , Ghent University, ; 9820 Merelbeke, Belgium
                Author information
                http://orcid.org/0000-0002-8198-2223
                Article
                108
                10.1186/s12610-020-00108-2
                7364779
                d2ed9977-7257-41b2-8867-5abafef1fc36
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 18 May 2020
                : 30 June 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001807, Fundação de Amparo à Pesquisa do Estado de São Paulo;
                Award ID: 2015/05419-5
                Award ID: 2013/25966-5
                Award ID: 2017/04102-3
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2020

                prostate,chien,fragmentation de l’adn,spermatozoïdes,finastéride,canine,dna fragmentation,sperm,finasteride

                Comments

                Comment on this article